BRPI0810957A2 - "emplasto medicamentoso compreendendo 5-metila-1-fenila-2-(1h) piridona". - Google Patents
"emplasto medicamentoso compreendendo 5-metila-1-fenila-2-(1h) piridona".Info
- Publication number
- BRPI0810957A2 BRPI0810957A2 BRPI0810957A BRPI0810957A BRPI0810957A2 BR PI0810957 A2 BRPI0810957 A2 BR PI0810957A2 BR PI0810957 A BRPI0810957 A BR PI0810957A BR PI0810957 A BRPI0810957 A BR PI0810957A BR PI0810957 A2 BRPI0810957 A2 BR PI0810957A2
- Authority
- BR
- Brazil
- Prior art keywords
- pyridone
- phenyl
- methyl
- medicated plaster
- medicated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/204—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with nitrogen-containing functional groups, e.g. aminoxides, nitriles, guanidines
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Materials Engineering (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007139653A JP5248040B2 (ja) | 2007-05-25 | 2007-05-25 | 5−メチル−1−フェニル−2−(1h)−ピリドン含有貼付剤 |
| PCT/JP2008/059672 WO2008146796A1 (ja) | 2007-05-25 | 2008-05-26 | 5-メチル-1-フェニル-2-(1h)-ピリドン含有貼付剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0810957A2 true BRPI0810957A2 (pt) | 2019-01-08 |
Family
ID=40075036
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0810957A BRPI0810957A2 (pt) | 2007-05-25 | 2008-05-26 | "emplasto medicamentoso compreendendo 5-metila-1-fenila-2-(1h) piridona". |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8287900B2 (pt) |
| JP (1) | JP5248040B2 (pt) |
| KR (1) | KR20100027139A (pt) |
| CN (1) | CN101754757A (pt) |
| BR (1) | BRPI0810957A2 (pt) |
| WO (1) | WO2008146796A1 (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080210265A1 (en) | 2007-03-01 | 2008-09-04 | Crawford Charles A | Coating removal composition |
| JP5192296B2 (ja) * | 2007-07-05 | 2013-05-08 | 日東電工株式会社 | 貼付剤および貼付製剤 |
| JP2010120912A (ja) * | 2008-11-21 | 2010-06-03 | Lead Chemical Co Ltd | 5−メチル−1−フェニル−2−(1h)−ピリドン含有貼付剤 |
| JP6014813B2 (ja) * | 2010-09-03 | 2016-10-26 | 株式会社 ケイ・エム トランスダーム | 経皮吸収製剤および皮膚貼付用粘着シート |
| CA2826218C (en) | 2011-02-02 | 2019-06-25 | Nitto Denko Corporation | A patch and patch preparation comprising a support and an adhesive layer |
| JP5698018B2 (ja) * | 2011-02-02 | 2015-04-08 | 日東電工株式会社 | 貼付剤および貼付製剤 |
| SG11201407544XA (en) | 2012-05-28 | 2014-12-30 | Abbex Ab | Composition for treatment of warts |
| TWI643638B (zh) * | 2013-08-09 | 2018-12-11 | 帝國製藥股份有限公司 | 含有貝前列素(Beraprost)之貼附劑 |
| CN105213351B (zh) * | 2013-09-25 | 2018-03-13 | 南阳市汇博生物技术有限公司 | 用于增生性疤痕修复的贴膜 |
| WO2018204523A1 (en) * | 2017-05-03 | 2018-11-08 | Kuefner George C | Systems and methods for treating skin conditions with magnesium ion compositions |
| KR20220051135A (ko) | 2019-05-13 | 2022-04-26 | 바이오 메드 사이언시즈, 인크. | 활성 성분 상처케어, 및 이의 흉터 관리 제품, 제조 방법 및 유용한 물품 |
| EP4003256B1 (en) * | 2019-07-30 | 2025-12-10 | The Government of The United States, as Represented by The Secretary of The Army | Layered composite for scar treatment and prevention |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1248450A (en) * | 1984-04-05 | 1989-01-10 | Kazuo Kigasawa | Soft patch |
| US5167649A (en) * | 1988-08-22 | 1992-12-01 | Zook Gerald P | Drug delivery system for the removal of dermal lesions |
| DE69810518D1 (de) * | 1998-09-18 | 2003-02-06 | Mepha Ag Aesch | Topisch verabreichbare alkyl-, phenyl-pyridone-arzneimittel |
| KR100777169B1 (ko) | 2001-01-29 | 2007-11-16 | 시오노기세이야쿠가부시키가이샤 | 5-메틸-1-페닐-2-(1h)-피리돈을 활성 성분으로서함유하는 의약 제제 |
| US20050266062A1 (en) * | 2002-11-05 | 2005-12-01 | Lead Ch Emical Co., Ltd. | Percutaneous absorption preparation containing 3-methyl-1-phenyl-2-pyrazolin-5-one |
| JP4542743B2 (ja) * | 2002-12-26 | 2010-09-15 | Kdl株式会社 | ピリドン誘導体の溶液状医薬組成物 |
| WO2004073713A1 (ja) * | 2003-02-21 | 2004-09-02 | Shionogi & Co., Ltd. | ピルフェニドンのゲル剤 |
| WO2004073680A1 (ja) * | 2003-02-21 | 2004-09-02 | Shionogi & Co., Ltd. | 液滴分散型軟膏剤 |
| JP2006298774A (ja) * | 2005-04-15 | 2006-11-02 | Lead Chemical Co Ltd | 経皮吸収型フリーラジカル抑制製剤 |
-
2007
- 2007-05-25 JP JP2007139653A patent/JP5248040B2/ja active Active
-
2008
- 2008-05-26 WO PCT/JP2008/059672 patent/WO2008146796A1/ja not_active Ceased
- 2008-05-26 US US12/451,646 patent/US8287900B2/en active Active
- 2008-05-26 KR KR1020097026380A patent/KR20100027139A/ko not_active Ceased
- 2008-05-26 CN CN200880100095A patent/CN101754757A/zh active Pending
- 2008-05-26 BR BRPI0810957A patent/BRPI0810957A2/pt not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR20100027139A (ko) | 2010-03-10 |
| US8287900B2 (en) | 2012-10-16 |
| US20100119584A1 (en) | 2010-05-13 |
| JP5248040B2 (ja) | 2013-07-31 |
| CN101754757A (zh) | 2010-06-23 |
| JP2008290984A (ja) | 2008-12-04 |
| WO2008146796A1 (ja) | 2008-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0810957A2 (pt) | "emplasto medicamentoso compreendendo 5-metila-1-fenila-2-(1h) piridona". | |
| FIC20250005I1 (fi) | Irinotekaanisukrosofaattisuola | |
| ATE532515T1 (de) | Stabile laquinimod-zubereitungen | |
| DK2234485T3 (da) | Stabile laquinimod-præparater | |
| EP1741703A4 (en) | pyridone | |
| CY2016040I2 (el) | Επιλογες θεραπειας για τη νοσο του fabry | |
| DK2073795T3 (da) | Misbrugssikret lægemiddelformulation | |
| DK2089364T3 (da) | Pyridinonforbindelser | |
| DK2117521T3 (da) | Transdermale indgivelsessystemer omfattende bupivacain | |
| EP1982978A4 (en) | PYRIDONE DERIVATIVES AND HERBICIDES | |
| DK1940467T3 (da) | Lægemiddelsammensætning med langvarig frigivelse | |
| DK2185142T3 (da) | Antiseptiske midler | |
| DK2144905T3 (da) | Terapeutiske midler | |
| DK2035369T3 (da) | Terapeutiske | |
| BRPI0808246A2 (pt) | "fralda descartável". | |
| DE602008006709D1 (de) | Funduskamera | |
| DK2001297T3 (da) | Aktivstofkombinationer insekticide egenskaber | |
| BRPI0716374A2 (pt) | "dispositivos médicos" | |
| BRPI0621731A2 (pt) | calças higiênicas descartáveis | |
| NO20043453D0 (no) | Loftebukk | |
| EP1745780A4 (de) | Medizinisches präparat | |
| ES1066752Y (es) | "jeringa" | |
| BRPI0719394A2 (pt) | Preparação medicinal sólida | |
| FI7793U1 (fi) | Kestosidehousut | |
| SE0400093D0 (sv) | Andningshjälpmedel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B12F | Other appeals [chapter 12.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
| B25A | Requested transfer of rights approved |
Owner name: LEAD CHEMICAL CO., LTD. (JP) |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07G | Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette] | ||
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |